Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Canaccord Genuity starts Braemar off at 'buy'

(Sharecast News) - Analysts at Canaccord Genuity initiated coverage on shipbroking services firm Braemar with a 'buy' rating and 410.0p target price on Wednesday, stating it was "all aboard for the super cycle". Canaccord Genuity noted that Braemar operates across multiple segments and geographies, offering broking services across a selective but diversified range of segments, including tankers, specialised tankers/products, dry cargo and offshore. It also offers sale and purchase advisory, corporate finance services and securities services.

The Canadian bank stated that with a refreshed and focused management team since 2023, it thinks the shares offer "a rare opportunity" to invest in a company where the fruits of a turnaround are only just starting.

"This reflects a company now refocused on areas of potential competitive advantage where we think Braemar is on the cusp of both compounding upside and outperforming," said Canaccord Genuity. "We see potential in the shares amplified by reduced debt leverage of equity - allowing scope for targeted additional growth (either through new hires or acquisitions). We see long-term EPS progress likely to be accompanied by PER expansion (recovery)."

Canaccord also believes the outperformance was also set to be potentially compounded as the maritime cycle was on the upward part of a potential "super cycle" - due to a shortage of new ship-building capacity and increasingly stringent environmental requirements in key markets.

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

GSK to pay $2.2bn to settle Zantac lawsuits
(Sharecast News) - GSK has agreed to pay $2.2bn to settle about 80,000 Zantac lawsuits in the US.
Tritax EuroBox accepts Brookfield £557m offer as Segro trumped
(Sharecast News) - Canadian investment form Brookfield has trumped Segro's effort to buy warehouse owner Tritax EuroBox with an agreed £557m offer.
Thursday preview: US CPI, ECB minutes in the spotlight
(Sharecast News) - All eyes on Thursday will be on the week's key data release, the US consumer price index for the month of September.
Bayer shares slump as US court approves review of Monsanto case
(Sharecast News) - Shares in Bayer slumped on Wednesday, after the Washington state Supreme Court said it would review a case alleging that exposure to products of the German chemicals company's Monsanto unit harmed three teachers.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.